Company Filing History:
Years Active: 2010-2013
Title: Innovations of Shinichi Miyake
Introduction
Shinichi Miyake is a notable inventor based in Kanonji, Japan. He has made significant contributions to the field of virology, particularly through his innovative work on flavivirus research. With a total of 2 patents, his inventions are paving the way for advancements in vaccine development.
Latest Patents
Miyake's latest patents include the development of an attenuated chimeric flavivirus that utilizes an attenuated Japanese encephalitis virus gene as its backbone. This invention features a nucleic acid molecule that contains nucleotide sequences encoding the capsid protein, pre-membrane protein, and non-structural protein of the Japanese encephalitis virus. Additionally, it includes a nucleotide sequence that encodes the envelope protein of a second flavivirus. The nucleotide sequences that encode the pre-membrane protein and/or non-structural protein of the Japanese encephalitis virus contain mutations that produce amino acid changes, effectively attenuating the virus.
Career Highlights
Shinichi Miyake is affiliated with Osaka University, where he continues to engage in groundbreaking research. His work is instrumental in enhancing our understanding of flavivirus and its implications for public health.
Collaborations
Miyake collaborates with esteemed colleagues such as Takeshi Nabeshima and Toshiyuki Onishi. Their combined expertise fosters a productive research environment that drives innovation in their field.
Conclusion
Shinichi Miyake's contributions to virology through his patents and collaborations highlight the importance of innovation in addressing health challenges. His work exemplifies the potential of scientific research to create impactful solutions.